{"altmetric_id":3647889,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"news":{"unique_users_count":1,"unique_users":["huffington_post"],"posts_count":1},"total":{"posts_count":2},"wikipedia":{"unique_users_count":1,"unique_users":["en:35642862"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa6353cf058f610008657","authors":["Jun Yan"],"doi":"10.1176\/pn.47.5.psychnews_47_5_1-b","endpage":"29","first_seen_on":"2015-02-15T03:48:40+00:00","isbns":[],"issns":["0033-2704","1559-1255"],"issue":"5","journal":"Psychiatric News","last_mentioned_on":1399062487,"links":["http:\/\/dsm.psychiatryonline.org\/newsarticle.aspx?articleid=1032188","http:\/\/psychnews.psychiatryonline.org\/newsArticle.aspx?articleid=1032188"],"pubdate":"2012-03-02T00:00:00+00:00","startpage":"1b","title":"Pipeline for New Antidepressants Flowing Slowly","type":"article","volume":"47"},"altmetric_score":{"score":13,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":13},"context_for_score":{"all":{"total_number_of_other_articles":6425180,"mean":5.8882976539633,"rank":439312,"this_scored_higher_than_pct":93,"this_scored_higher_than":5979904,"rank_type":"exact","sample_size":6425180,"percentile":93},"similar_age_3m":{"total_number_of_other_articles":207057,"mean":8.8233522138939,"rank":22095,"this_scored_higher_than_pct":89,"this_scored_higher_than":184829,"rank_type":"exact","sample_size":207057,"percentile":89},"this_journal":{"total_number_of_other_articles":570,"mean":5.7519121265378,"rank":52,"this_scored_higher_than_pct":91,"this_scored_higher_than":520,"rank_type":"exact","sample_size":570,"percentile":91},"similar_age_this_journal_3m":{"total_number_of_other_articles":42,"mean":2.9329268292683,"rank":1,"this_scored_higher_than_pct":97,"this_scored_higher_than":41,"rank_type":"exact","sample_size":42,"percentile":97}}},"demographics":[],"posts":{"wikipedia":[{"title":"Edivoxetine","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=489575771#altmetric_citation_0","license":"public","citation_ids":[3647889],"posted_on":"2012-04-28T04:33:00+00:00","summary":"Edivoxetine (INN; LY-2216684) is a drug which acts as a selective norepinephrine reuptake inhibitor and is currently under development by Eli Lilly for attention-deficit hyperactivity disorder (ADHD) and as an antidepressant treatment.","page_url":"http:\/\/en.wikipedia.org\/?curid=35642862","wiki_lang":"en","author":{"name":"Vanished 45kd09la13","url":"http:\/\/en.wikipedia.org\/wiki\/User:Vanished 45kd09la13"}}],"news":[{"title":"Why Antidepressants Won't Solve the Depression Epidemic","url":"http:\/\/www.huffingtonpost.com\/jonathan-rottenberg\/why-antidepressants-wont-_b_5191625.html","license":"public","citation_ids":[127218,173589,117090,1530229,2293169,2424817,100678,506803,562637,408530,2322463,1425838,463311,3647889],"posted_on":"2014-05-02T20:28:07+00:00","summary":"Some 35 million American adults struggle with depression. The World Health Organization projects that by 2030, the amount of disability and life lost due to depression will be greater than that of any other condition, including accidents, war, suicide, can","author":{"name":"Huffington Post","url":"http:\/\/www.huffingtonpost.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/359\/normal\/image.png?1448021240"}}]}}